Purine derivatives as potent gamma-secretase modulators

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Pharmacology

Background:

• Alzheimer's disease is characterized by amyloid-beta (Aβ) plaque accumulation.
• Gamma-secretase is a key enzyme in amyloid-beta production.
• Previous research focused on pyrimidine-based gamma-secretase modulators.

Purpose of the Study:

• To develop novel purine-based gamma-secretase modulators.
• To achieve selective modulation of gamma-secretase activity.
• To reduce amyloid-beta 42 levels for Alzheimer's disease therapy.

Main Methods:

• Chemical synthesis and optimization of purine derivatives.
• In vitro assays to determine enzyme inhibition and selectivity.
• In vivo studies using an APP-YAC transgenic mouse model.

Main Results:

• A novel series of purine compounds were synthesized.
• Compounds exhibited 300- to 2000-fold selectivity for gamma-secretase over Notch cleavage.
• Selective reduction of amyloid-beta 42 was observed in a mouse model.

Conclusions:

• The developed purine series represents potent and selective gamma-secretase modulators.
• These compounds offer a potential therapeutic strategy for Alzheimer's disease.
• Further investigation is warranted for clinical development.